Expression of a transgene encoding mutant p193/CUL7 preserves cardiac function and limits infarct expansion after myocardial infarction

Heart

Volumn 95, Issue 14, 2009, Pages 1159-1164

  Hassink, R J ^a   Nakajima, H ^b   Nakajima, H O ^b   Doevendans, P A ^a   Field, L J ^b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; BINDING PROTEIN CUL7; BINDING PROTEIN P193; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HEART FUNCTION; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE PRESSURE; HEART LEFT VENTRICLE VOLUME; HEART VENTRICLE CONTRACTION; HEART VENTRICLE REMODELING; MORPHOMETRICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; RELAXATION TIME; SCAR FORMATION; TRANSGENE; TRANSGENIC MOUSE; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CICATRIX; CULLIN PROTEINS; HEMODYNAMICS; MICE; MICE, TRANSGENIC; MUTATION; MYOCARDIAL INFARCTION; MYOCARDIUM; TRANSGENES; VENTRICULAR REMODELING;

EID: 67650077704     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/hrt.2008.150128     Document Type: Article

References (46)

1. Olivetti G, Quaini F, Sala R, et al. Acute myocardial infarction in humans is associated with activation of programmed myocyte cell death in the surviving portion of the heart. J Mol Cell Cardiol 1996;28:2005-16.
2. Abbate A, Biondi-Zoccai GG, Bussani R, et al. Increased myocardial apoptosis in patients with unfavorable left ventricular remodeling and early symptomatic postinfarction heart failure. J Am Coll Cardiol 2003;41:753-60.
3. Narula J, Haider N, Virmani R, et al. Apoptosis in myocytes in end-stage heart failure. N Engl J Med 1996;335:1182-9.
4. Pasumarthi KB, Field LJ. Cardiomyocyte cell cycle regulation. Circ Res 2002;90:1044-54.
5. Dowell JD, Rubart M, Pasumarthi KB, et al. Myocyte and myogenic stem cell transplantation in the heart. Cardiovasc Res 2003;58:336-50.
6. Hassink RJ, Dowell JD, Brutel de la Riviere A, et al. Stem cell therapy for ischemic heart disease. Trends Mol Med 2003;9:436-41.
7. Field LJ. Atrial natriuretic factor-SV40 T antigen transgenes produce tumors and cardiac arrhythmias in mice. Science 1988;239:1029-33.
8. Behringer RR, Peschon JJ, Messing A, et al. Heart and bone tumors in transgenic mice. Proc Natl Acad Sc USA 1988;85:2648-52.
9. Katz EB, Steinhelper ME, Delcarpio JB, et al. Cardiomyocyte proliferation in mice expressing alpha-cardiac myosin heavy chain-SV40 T-antigen transgenes. Am J Physiol 1992;262:H1867-76.
10. Daud AI, Lanson NA Jr, Claycomb WC, et al. Identification of SV40 large T-antigen-associated proteins in cardiomyocytes from transgenic mice. Am J Physiol 1993;264:H1693-700.
11. Tsai SC, Pasumarthi KB, Pajak L, et al. Simian virus 40 large T antigen binds a novel Bcl-2 homology domain 3-containing proapoptosis protein in the cytoplasm. J Biol Chem 2000;275:3239-46.
12. Pasumarthi KB, Tsai SC, Field LJ. Coexpression of mutant p53 and p193 renders embryonic stem cell-derived cardiomyocytes responsive to the growth-promoting activities of adenoviral E1A. Circ Res 2001;88:1004-11.
13. Huh NE, Pasumarthi KB, Soonpaa MH, et al. Functional abrogation of p53 is required for T-Ag induced proliferation in cardiomyocytes. J Mol Cell Cardiol 2001;33:1405-19.
14. Classon M, Harlow E. The retinoblastoma tumour suppressor in development and cancer. Nat Rev Cancer 2002;2:910-17.
15. Vousden KH, Lu X. Live or let die: the cell's response to p53. Nat Rev Cancer 2002;2:594-604.
16. Dias DC, Dolios G, Wang R, et al. CUL7: a DOC domain-containing cullin selectively binds Skp1.Fbx29 to form an SCF-like complex. Proc Natl Acad Sci USA 2002;99:16601-6.
17. Arai T, Kasper JS, Skaar JR, et al. Targeted disruption of p185/Cul7 gene results in abnormal vascular morphogenesis. Proc Natl Acad Sci USA 2003;100:9855-60.
18. Nakajima H, Nakajima HO, Tsai SC, et al. Expression of mutant p193 and p53 permits cardiomyocyte cell cycle reentry after myocardial infarction in transgenic mice. Circ Res 2004;94:1606-14.
19. Gulick J, Subramaniam A, Neumann J, et al. Isolation and characterization of the mouse cardiac myosin heavy chain genes. J Biol Chem 1991;266:9180-85.
20. Reddy VB, Thimmappaya B, Dhar R, et al. The genome of simian virus 40. Science 1978;200:494-502.
21. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-5.
22. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979;76:4350-54.
23. Georgakopoulos D, Kass DA. Estimation of parallel conductance by dual-frequency conductance catheter in mice. Am J Physiol Heart Circ Physiol 2000;279:H443-50.
24. Feldman MD, Mao Y, Valvano JW, et al. Development of a multifrequency conductance catheter-based system to determine LV function in mice. Am J Physiol Heart Circ Physiol 2000;279:H1411-20.
25. Bullock GR, Petrusz P. Techniques in immunocytochemistry. London, New York: Academic Press, 1982.
26. Sweat F, Puchtler H, Rosenthal SI. Sirius red F3ba as a stain for connective tissue. Arch Pathol 1964;78:69-72.
27. Pfeffer JM, Pfeffer MA, Fletcher PJ, et al. Progressive ventricular remodeling in rat with myocardial infarction. Am J Physiol 1991;260:H1406-14.
28. Glower DD, Spratt JA, Snow ND, et al. Linearity of the Frank-Starling relationship in the intact heart: the concept of preload recruitable stroke work. Circulation 1985;71:994-1009.
29. Swynghedauw B. Molecular mechanisms of myocardial remodeling. Physiol Rev 1999;79:215-62.
30. Kaab S, Nuss HB, Chiamvimonvat N, et al. Ionic mechanism of action potential prolongation in ventricular myocytes from dogs with pacing-induced heart failure. Circ Res 1996;78:262-73.
31. Ito K, Yan X, Tajima M, et al. Contractile reserve and intracellular calcium regulation in mouse myocytes from normal and hypertrophied failing hearts. Circ Res 2000;87:588-95.
32. Litwin SE, Zhang D, Bridge JH. Dyssynchronous Ca(2+) sparks in myocytes from infarcted hearts. Circ Res 2000;87:1040-7.
33. Houser SR, Margulies KB. Is depressed myocyte contractility centrally involved in heart failure? Circ Res 2003;92:350-8.
34. Esposito G, Rapacciuolo A, Naga Prasad SV, et al. Genetic alterations that inhibit in vivo pressure-overload hypertrophy prevent cardiac dysfunction despite increased wall stress. Circulation 2002;105:85-92.
35. Pasumarthi KB, Nakajima H, Nakajima HO, et al. Targeted expression of cyclin D2 results in cardiomyocyte DNA synthesis and infarct regression in transgenic mice. Circ Res 2005;96:110-8.
36. Soonpaa MH, Koh GY, Pajak L, et al. Cyclin D1 overexpression promotes cardiomyocyte DNA synthesis and multinucleation in transgenic mice. J Clin Invest 1997;99:2644-54.
37. Xiao G, Mao S, Baumgarten G, et al. Inducible activation of c-Myc in adult myocardium in vivo provokes cardiac myocyte hypertrophy and reactivation of DNA synthesis. Circ Res 2001;89:1122-9.
38. Liao HS, Kang PM, Nagashima H, et al. Cardiac-specific overexpression of cyclin-dependent kinase 2 increases smaller mononuclear cardiomyocytes. Circ Res 2001;88:443-50.
39. Pasumarthi KB, Nakajima H, Nakajima HO, et al. Enhanced cardiomyocyte DNA synthesis during myocardial hypertrophy in mice expressing a modified TSC2 transgene. Circ Res 2000;86:1069-77.
40. Chaudhry HW, Dashoush NH, Tang H, et al. Cyclin A2 mediates cardiomyocyte mitosis in the postmitotic myocardium. J Biol Chem 2004;279:35858-66.
41. Reiss K, Cheng W, Ferber A, et al. Overexpression of insulin-like growth factor-1 in the heart is coupled with myocyte proliferation in transgenic mice. Proc Natl Acad Sci USA 1996;93:8630-5.
42. Limana F, Urbanek K, Chimenti S, et al. Bcl-2 overexpression promotes myocyte proliferation. Proc Natl Acad Sci USA 2002;99:6257-62.
43. Engel FB, Schebesta M, Duong MT, et al. p38 MAP kinase inhibition enables proliferation of adult mammalian cardiomyocytes. Genes Dev 2005;19:1175-87.
44. Hassink RJ, Pasumarthi KB, Nakajima H, et al. Cardiomyocyte cell cycle activation improves cardiac function after myocardial infarction. Cardiovasc Res 2008;78:18-25.
45. Li Q, Li B, Wang X, et al. Overexpression of insulin-like growth factor-1 in mice protects from myocyte death after infarction, attenuating ventricular dilation, wall stress, and cardiac hypertrophy. J Clin Invest 1997;100:1991-9.
46. Okabe H, Lee SH, Phuchareon, et al. A critical role for FBXW8 and MAPK in cyclin D1 degradation and cancer cell proliferation. Plos One 2006;1:e128.